Atherosclerosis and restenosis are two cardiovascular diseases which alter cardiac function and produce considerable morbidity and mortality. Gene therapy treatments to these diseases hold considerable promise, but a major obstacle to their implementation is the development of appropriate animal models and the investigation of molecular mechanisms of vascular pathophysiology. A major interest of my laboratory is to develop animal models of vascular disease based upon direct gene transfer of recombinant growth factor genes which will facilitate the understanding the treatment of cardiovascular diseases. The purpose of this proposal is to study the basic biology of growth factor gene expression and to develop gene therapy approaches to treat cardiovascular diseases. Transforming growth factor beta (TGF-beta) genes will be examined since this growth factor regulates cellular proliferation and connective tissue production following vascular injury. We will use direct gene transfer to transfect recombinant TGF-beta genes into vascular cells in porcine arteries in vivo. Expression of TGF-beta genes in normal and injured arteries will permit characterization of gene expression and function, and the design of gene products which might regulate and modify TGF-beta induced changes. We have previously developed methods for cell-mediated and direct gene transfer of recombinant genes into the vasculature. These studies have established the feasibility for the proposed experiments by demonstrating that recombinant genes can be expressed in the vasculature. Gene expression can be confirmed at the DNA, mRNA and protein level, and the effect of the recombinant gene product on vascular cells can be analyzed. In this proposal, we plan to develop an animal model of recombinant TGF-beta gene expression (TGF -beta1, -beta2 and -beta3) in normal porcine arteries following direct gene transfer, to confirm gene expression, and to investigate the effects of TGF-beta on these arteries. Second, we will investigate the mechanism of recombinant TGF-beta regulation of vascular growth in transduced arteries by characterizing collagen synthesis, cell proliferation, and release of growth factors and cytokines. Third, the effect of TGF-beta gene expression on intimal proliferation and connective tissue production in injured arteries will be investigated. Preliminary data suggest that expression of TGF-beta could help to modify the response to injury. These systems can also be used to develop antagonists to TGF-beta which can further define and/or treat vascular diseases. Such agents, including dominant negative inhibitors, antisense oligonucleotides or other antagonists, will be analyzed as part of future studies beyond the scope of this proposal. In summary, these studies will develop animal models of vascular disease from direct gene transfer of recombinant TGF-beta into normal and injured porcine arteries. Studies of basic biology of gene expression will be conducted and molecular genetic interventions which target TGF-beta will be developed to treat cardiovascular diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK042706-04
Application #
3243886
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Project Start
1990-08-01
Project End
1998-07-31
Budget Start
1993-08-01
Budget End
1994-07-31
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Schott, E; Tostes, R C; San, H et al. (1997) Expression of a recombinant preproendothelin-1 gene in arteries stimulates vascular contractility. Am J Physiol 272:H2385-93
Nabel, G J; Gordon, D; Bishop, D K et al. (1996) Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes. Proc Natl Acad Sci U S A 93:15388-93
Muller, D W; Gordon, D; San, H et al. (1994) Catheter-mediated pulmonary vascular gene transfer and expression. Circ Res 75:1039-49
Nabel, E G; Yang, Z; Muller, D et al. (1994) Safety and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastatic melanoma. Hum Gene Ther 5:1089-94
Nabel, E G; Yang, Z; Liptay, S et al. (1993) Recombinant platelet-derived growth factor B gene expression in porcine arteries induce intimal hyperplasia in vivo. J Clin Invest 91:1822-9
Nabel, E G; Shum, L; Pompili, V J et al. (1993) Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci U S A 90:10759-63
Nabel, E G; Plautz, G; Nabel, G J (1992) Transduction of a foreign histocompatibility gene into the arterial wall induces vasculitis. Proc Natl Acad Sci U S A 89:5157-61
Plautz, G; Nabel, E G; Nabel, G J (1991) Introduction of vascular smooth muscle cells expressing recombinant genes in vivo. Circulation 83:578-83
Plautz, G; Nabel, E G; Nabel, G J (1991) Selective elimination of recombinant genes in vivo with a suicide retroviral vector. New Biol 3:709-15
Nabel, E G; Plautz, G; Nabel, G J (1990) Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science 249:1285-8